Showing results (801-810 of 820) with videos related to

Sort By:
Pageof 82
Chemical Science|August 21, 2018
Correction: Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 1, 2022
Inconsistent language lateralisation - Testing the dissociable language laterality hypothesis using behaviour and lateralised cerebral blood flow, Adam J Parker, Zoe V J Woodhead, et al.
Frontiers in Neurology|September 25, 2023
Impact of e-ASPECTS software on the performance of physicians compared to a consensus ground truth: a multi-reader, multi-case studyHassan Kobeissi, David F Kallmes, John Benson, et al.
BMC Health Services Research|March 16, 2025
The National Paediatric Applied Research Translation Initiative (N-PARTI): using implementation science to improve primary care for Australian children with asthma, type 1 diabetes, and infectionsJeffrey Braithwaite, Georgia Fisher, Reema Harrison, et al.
Journal of Medicinal Chemistry|July 29, 2008
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug designPaul G Wyatt, Andrew J Woodhead, Valerio Berdini, et al.
Nature Communications|February 27, 2025
Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E functionSwee Y Sharp, Marianna Martella, Sabrina D'Agostino, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
Plos One|February 6, 2016
Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available EvidenceAmanda Jefferson, Helen Leonard, Aris Siafarikas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activityTimothy A Yap, Mike I Walton, Kyla M Grimshaw, et al.
The Lancet. Child & Adolescent Health|March 20, 2025
Trajectories of depressive symptoms among young people in London, UK, and Tokyo, Japan: a longitudinal cross-cohort studyGemma Knowles, Daniel Stanyon, Syudo Yamasaki, et al.
Pageof 82